Paul Michael Haller

16PUBLICATIONS
66CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Chemical and thermal processes in energy and combustionCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 16, 2026
Early versus delayed evolocumab treatment and complex coronary artery revascularization.

|Apr 21, 2026
Diagnostic validation and prognostic implications of serial 0/1/3h stratification in patients with suspected myocardial infarction using high-sensitivity troponin T.

|Sep 15, 2025
Galectin-3 and kidney function in type 2 diabetes treated with dapagliflozin: Analysis from DECLARE-TIMI 58.

Paul M Haller, Stephen D Wiviott, David D Berg

|Aug 30, 2025
Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure.

David D Berg, Siddharth M Patel, Paul M Haller

|Aug 19, 2025
Bedside echocardiography in patients with suspected acute myocardial infarction without ST elevation.

Paul Michael Haller, Alina Schock, Caroline Kellner

|Jun 07, 2024
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis.

Paul M Haller, Niema Kazem, Stefan Agewall

Pageof 3

Frequent Collaborators

4 joint publications

Raphael Twerenbold

4 joint publications

Betül Toprak

4 joint publications

Alina Goßling

3 joint publications

Jonas Lehmacher